Incyte Corp (INCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Sales | 1,052,898 | 1,178,698 | 1,137,871 | 1,043,759 | 880,889 |
| Cost of Goods | 73,188 | 88,485 | 85,993 | 76,634 | 60,956 |
| Gross Profit | 979,710 | 1,090,213 | 1,051,878 | 967,125 | 819,933 |
| Operating Expenses | 774,730 | 789,185 | 906,786 | 1,445,889 | 728,991 |
| Operating Income | 205,168 | 301,513 | 146,085 | -478,130 | 91,898 |
| Interest Expense | 660 | 419 | 774 | 657 | 430 |
| Other Income | 29,682 | 12,630 | 11,213 | 89,010 | 144,691 |
| Pre-tax Income | 234,190 | 313,724 | 156,524 | -389,777 | 236,159 |
| Income Tax | 75,987 | 112,512 | 50,068 | 54,824 | 66,611 |
| Net Income Continuous | 158,203 | 201,212 | 106,456 | -444,601 | 169,548 |
| Net Income | $158,203 | $201,212 | $106,456 | $-444,601 | $169,548 |
| EPS Basic Total Ops | 0.82 | 0.89 | 0.55 | -2.04 | 0.76 |
| EPS Basic Continuous Ops | 0.82 | 0.89 | 0.55 | -2.04 | 0.76 |
| EPS Diluted Total Ops | 0.80 | 0.90 | 0.54 | -2.04 | 0.75 |
| EPS Diluted Continuous Ops | 0.80 | 0.90 | 0.54 | -2.04 | 0.75 |
| EPS Diluted Before Non-Recurring Items | 0.89 | 1.09 | 0.73 | -2.03 | 0.38 |
| EBITDA(a) | $227,530 | $324,246 | $168,605 | $-456,082 | $113,845 |